Browse > Article
http://dx.doi.org/10.5765/jkacap.2012.23.1.31

A Case Report of Noonan Syndrome with Mental Retardation and Attention-Deficit Hyperactivity Disorder  

Kim, Won-Woo (Department of Psychiatry, Soonchunhyang University Cheonan Hospital)
Shim, Se-Hoon (Department of Psychiatry, Soonchunhyang University Cheonan Hospital)
Publication Information
Journal of the Korean Academy of Child and Adolescent Psychiatry / v.23, no.1, 2012 , pp. 31-35 More about this Journal
Abstract
Noonan syndrome is characterized by short stature, typical facial dysmorphology, and congenital heart defects. The main facial features of Noonan syndrome are hypertelorism with down-slanting palpebral fissures, ptosis, and low-set posteriorly-rotated ears with a thickened helix. The cardiovascular defects most commonly associated with this condition are pulmonary stenosis and hypertrophic cardiomyopathy. Other associated features are webbed neck, chest deformity, mild intellectual deficit, cryptorchidism, poor feeding in infancy, bleeding tendency, and lymphatic dysplasias. The patient is a 10-year-old boy. He had experienced repeated febrile convulsions. He had typical facial features, a short stature, chest deformity, cryptorchidism, vesicoureteral reflux, and mental retardation. His language and motor development were delayed. When he went to school, it was difficult for him to pay attention, follow directions, and organize tasks. He also displayed behavior such as squirming, leaving his seat in class, and running around inappropriately. Clinical observation is important for the diagnosis, so we report a patient who was diagnosed with Noonan syndrome, mental retardation, and attention-deficit hyperactivity disorder.
Keywords
Noonan Syndrome; Mental Retardation; Attention-Deficit Hyperactivity Disorder;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hernandez A, Barragan P. Efficacy of atomoxetine treatment in children with ADHD and epilepsy. Epilepsia 2005;46:718.
2 Shaw AC, Kalidas K, Crosby AH, Jeffery S, Patton MA. The natural history of Noonan syndrome: a long-term follow-up study. Arch Dis Child 2007;92:128-132.   DOI
3 Troyer AK, Joschko M. Cognitive characteristics associated with Noonan syndrome : two case reports. Child Neuropsychology 1997; 3:199-205.   DOI   ScienceOn
4 Sharland M, Burch M, McKenna WM, Paton MA. A clinical study of Noonan syndrome. Arch Dis Child 1992;67:178-183.   DOI   ScienceOn
5 Horiguchi T, Takeshita K. Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment. Brain Dev 2003;25:291-293.   DOI   ScienceOn
6 Blondis TA. Motor disorders and attention-deficit/hyperactivity disorder. Pediatr Clin North Am 1999;46:899-913, vi-vii.   DOI
7 Mulligan S. An analysis of score patterns of children with attention disorders on the Sensory Integration and Praxis Tests. Am J Occup Ther 1996;50:647-654.   DOI
8 Sarimski K. Developmental and behavioural phenotype in Noonan syndrome? Genet Couns 2000;11:383-390.
9 Verhoeven WM, Hendrikx JL, MDoorakkers MC, Egger JI, Van der Burgt I, Tuinier S. Alexithymia in Noonan syndrome. Genet Couns 2004;15:47-52.
10 Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood. Dev Med Child Neurol 2003;45:50-54.
11 Bauchner H. ADHD: A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder. Arch Dis Child 2000;83:63.   DOI
12 Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav 2008;12:217-233.   DOI   ScienceOn
13 Wernicke JF, Holdridge KC, Jin L, Edison T, Zhang S, Bangs ME, et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007;49: 498-502.   DOI   ScienceOn
14 Allanson JE. Noonan syndrome. J Med Genet 1987;24:9-13.   DOI
15 Opitz JM. The Noonan syndrome. Am J Med Genet 1985;21:515-518.   DOI   ScienceOn
16 Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994;8:357-360.   DOI   ScienceOn
17 Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001; 29:465-468.   DOI   ScienceOn
18 Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, et al. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002;70:1555-1563.   DOI   ScienceOn
19 Kitchens CS, Alexander JA. Partial deficiency of coagulation factor XI as a newly recognized feature of Noonan syndrome. J Pediatr 1983;102:224-227.   DOI
20 Money J, Kalus ME Jr. Noonan's syndrome. IQ and specific disabilities. Am J Dis Child 1979;133:846-850.   DOI
21 van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E. Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 1994;53:187-191.   DOI   ScienceOn
22 Allanson JE. Noonan syndrome. In: Cassidy SB, Allanson JE, editors. Management of genetic syndromes. 2nd edition. New York: Wiley-Liss;2005. p.385-397.
23 Wingbermuehle E, Egger J, van der Burgt I, Verhoeven W. Neuropsychological and behavioral aspects of Noonan syndrome. Horm Res 2009;72 Suppl 2:15-23.
24 van der Burgt I, Thoonen G, Roosenboom N, Assman-Hulsmans C, Gabreels F, Otten B, et al. Patterns of cognitive functioning in schoolaged children with Noonan syndrome associated with variability in phenotypic expression. J Pediatr 1999;135:707-713.   DOI   ScienceOn
25 Opitz JM, Summitt RL, Sarto GE. Noonan's syndrome in girls: a genocopy of the Ullrich-Turner syndrome. J Pediatr 1965;67:968.
26 Lee DA, Portnoy S, Hill P, Gillberg C, Patton MA. Psychological profile of children with Noonan syndrome. Dev Med Child Neurol 2005;47:35-38.   DOI   ScienceOn
27 Noonan JA, Ehmke DA. Associated noncardiac malformation in children with congenital heart disease. J Pediatr 1963;63:468.